Welcome to the e-CCO Library!

P620: Pivoting in a pandemic: The impact of COVID-19 on the provision of care for patients with Inflammatory Bowel Disease – A retrospective study
Year: 2021
Source: ECCO'21 Virtual
Authors: Malhi, G.(1);Chambers, J.(1);Minhas, G.(1);Mikail, M.(1);Khanna, R.(2);Wilson, A.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P620: Stapled end-to-side vs. side-to-side anastomosis after ileocecectomy for Crohn’s disease: a propensity score-matched analysis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Brandstetter1, M. Gouvea Monteiro de Camargo1, A. Aiello2, L. Stocchi1, J. M. Church1, T. Hull1, I. Lavery1, S. R. Steele1, S. Holubar*1, M. Valente1

Created: Friday, 22 February 2019, 9:41 AM
P621 Physician preferences for biologics (originator vs. biosimilar) for the treatment of ulcerative colitis in France, Germany and the UK
Year: 2020
Source:

ECCO'20 Vienna

Authors:

L. Huynh1, S. Hass2, B.E. Sands3, M.S. Duh1, H. Sipsma1, M. Cheng1, A. Lax1, A. NAG4

Created: Thursday, 30 January 2020, 10:12 AM
P621: Combination treatment of biologics with immunomodulator increases risk of infection after discharge in biologics naive steroid refractory acute severe ulcerative colitis patient: A KASID multicenter study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kim, S.J.(1)*;Lee, J.(1);Kim, D.H.(2);Park, S.H.(3);Kim, E.S.(4);Kim, K.O.(5);Lee, Y.J.(6);Song, E.M.(7);Kim, D.S.(8);
Created: Friday, 14 July 2023, 11:05 AM
P621: Efficacy and safety of golimumab in ulcerative colitis. Preliminary data from a multicenter Italian study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Bossa F.*1, Valvano M.R.1, Costantino G.2, Vinci E.3, Rispo A.4, Mendolaro M.5, Patturelli M.6, Shaini E.7, Mazzuoli S.8, RIcciardelli C.9, Tursi A.10, Lauria A.11, Paese P.12, Azzarone A.13, Sebkova L.14, Pranzo G.15, Fries W.2, Castiglione F.4, Cappello M.5, Privitera A.3, Principi B.7, Andriulli A.1

Created: Wednesday, 20 February 2019, 10:36 AM
P621: Faecal calprotectin after the induction of anti-TNF therapy predicts mucosal healing in patients with ulcerative colitis: A prospective single-centre study
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Bertani1*, N. de Bortoli1, L. Ceccarelli2, G. Mumolo2, G. Tapete1, E. Albano1, G. Laino1, G. Di Fluri2, M. Bellini2, A. Ricchiuti2, S. Marchi1, F. Costa2

Created: Thursday, 21 February 2019, 9:14 AM
P621: Lactose intolerance assessed by analysis of genetic polymorphism, breath test and symptoms in patients with inflammatory bowel disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Nardone, O.M.(1);Manfellotto, F.(2);D'Onofrio, C.(1);Rocco, A.(1);Annona, G.(2);Sasso, F.(1);De Luca, P.(2);Imperatore, N.(3);Testa, A.(1);de Sire, R.(1);Biffali, E.(2);Castiglione, F.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P621: Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive Crohn’s disease patients: results from the EVOLVE study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. Bressler*1, G. Mantzaris2, M. Silverberg3, P. Zezos3, D. Stein4, C. Colby5, T. Lissoos6, C. Lopez6, A. Natsios7, G. Radulescu8, H. Patel9, D. Demuth10, A. Yarur11

Created: Friday, 22 February 2019, 9:41 AM
P621: Secure Electronic Document Signing Uptake in Biologic Prescribing for Immune Mediate Diseases
Year: 2022
Source: ECCO'22
Authors: Sharma, S.(1);Jones, J.(1);Stewart, M.(1);
Created: Friday, 11 February 2022, 3:56 PM
P622 Recovery of nutrient deficiency as a predictor of remission in inflammatory bowel diseases
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A.A. Iakovlev, A. Volkov, I. Shcherbakova, G. Leonova, V. Piskovets

Created: Thursday, 30 January 2020, 10:12 AM
P622: Change in Dietary Inflammatory Index Score in patients with Crohn's disease and healthy volunteers following the Groningen Anti Inflammatory Diet (GrAID)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: BarthDrs., I.(1)*;Stevens, C.L.(1);Campmans-Kuijpers, M.J.E.(1);Dijkstra, G.(1);
Created: Friday, 14 July 2023, 11:05 AM
P622: Child outcome in IBD pregnancy: early vs. late discontinuation of IFX therapy
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. Truta*1, T. Bayless1, J. Canner1, S. Bashar1

Created: Friday, 22 February 2019, 9:41 AM
P622: Comparison of long-term outcomes of infliximab and adalimumab in biologic-naïve patients with ulcerative colitis
Year: 2022
Source: ECCO'22
Authors: Durak, M.B.(1);Baspınar, B.(1);Guven, I.E.(1);Kivrakoglu, F.(1,2);Kilic, V.(1);Kosar, K.(1);Erdogan, C.(1);Yüksel, I.(1,2);
Created: Friday, 11 February 2022, 3:56 PM
P622: Comparison of midterm outcomes in Pediatric Crohn’s Disease patients treated with either Exclusive Enteral Nutrition or Corticosteroids around disease diagnosis– a population based study
Year: 2021
Source: ECCO'21 Virtual
Authors: Plotkin, L.(1);Focht, G.(1);Harel, S.(1);Dotan, I.(2);Greenfeld, S.(3);Kariv, R.(3);Gabay, H.(4);Loewenberg Weisband, Y.(4);Turner, D.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P622: Efficacy of probiotics in inflammatory bowel disease: systematic review and meta-analysis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Derwa Y.1, Gracie D.J.*1,2, Hamlin P.J.1, Ford A.C.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P623 Cumulative incidence of infliximab use after a first flare of acute severe colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. GHRIBI, G. Mohamed, S. Bizid, B. Ben Sliman, K. Boughoula, H. Ben Abdallah, R. Bouali, M.N. Abdelli

Created: Thursday, 30 January 2020, 10:12 AM
P623: Colorectal cancer, colectomy rates and inflammatory bowel disease activity following liver transplantation in primary sclerosing cholangitis: a systematic review and meta-analysis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

T. Thomas*1, R. Cooney2, T. Iqbal2,3, S. Ghosh2,3, J. Ferguson3,4, G. Hirschfield5, P. Trivedi3,4,6,7

Created: Friday, 22 February 2019, 9:41 AM
P623: Mucosal eosinophils as markers of post-induction vedolizumab response in paediatric Ulcerative Colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Musto, F.(1)*;Ranalli, M.(2);Giordano, C.(3);Bianchi, E.(2);Veraldi, S.(4);Oliva, S.(5);D'Arcangelo, G.(2);Aloi, M.(2);
Created: Friday, 14 July 2023, 11:05 AM
P623: Quality of life as predictor of biological levels decay in inflammatory bowel diseases
Year: 2018
Source: ECCO '18 Vienna
Authors:

D. Ceballos1*, M.D. Fiuza2, I. Alarcón3

Created: Thursday, 21 February 2019, 9:14 AM